HEFFLER, Enrico Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.969
EU - Europa 1.806
AS - Asia 1.089
AF - Africa 273
SA - Sud America 46
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.231
Nazione #
US - Stati Uniti d'America 6.879
SG - Singapore 520
FI - Finlandia 389
IE - Irlanda 311
CN - Cina 285
DE - Germania 264
NG - Nigeria 259
IT - Italia 225
FR - Francia 136
NL - Olanda 117
GB - Regno Unito 83
CA - Canada 72
SE - Svezia 67
IN - India 64
TW - Taiwan 40
BE - Belgio 38
BR - Brasile 38
AU - Australia 37
CZ - Repubblica Ceca 37
TR - Turchia 36
KR - Corea 33
RU - Federazione Russa 31
HK - Hong Kong 25
CH - Svizzera 23
ES - Italia 22
JP - Giappone 19
IL - Israele 18
MX - Messico 17
PK - Pakistan 10
AT - Austria 8
RO - Romania 8
ID - Indonesia 7
NO - Norvegia 7
PL - Polonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DK - Danimarca 5
EG - Egitto 5
GR - Grecia 5
IQ - Iraq 5
SA - Arabia Saudita 5
VN - Vietnam 5
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
UA - Ucraina 4
AR - Argentina 3
CL - Cile 3
GM - Gambi 3
IR - Iran 3
MY - Malesia 3
PT - Portogallo 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
SI - Slovenia 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
ET - Etiopia 1
JO - Giordania 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 10.231
Città #
Chandler 1.322
Wilmington 1.289
San Mateo 482
Ann Arbor 415
Helsinki 386
Singapore 314
Dublin 292
Benin City 259
Boardman 245
Lawrence 234
Princeton 234
Leawood 221
Shanghai 184
New York 157
Fairfield 124
Ashburn 117
Paris 108
Woodbridge 107
Amsterdam 92
Toronto 57
London 51
Seattle 44
Santa Clara 39
San Diego 35
Redwood City 34
Kocaeli 30
Norwalk 30
Brussels 29
Menlo Park 28
Milan 22
Munich 22
Pune 22
Monmouth Junction 21
Brno 20
Beijing 19
Los Angeles 18
Newark 17
Phoenix 16
Falls Church 15
Buffalo 12
Houston 11
Hyderabad 11
Melbourne 11
Moscow 10
Redmond 10
Nuremberg 9
Prague 9
Des Moines 8
Olomouc 8
Pergine Valsugana 8
Rome 8
Turin 8
Cambridge 7
Falkenstein 7
Genoa 7
Jakarta 7
Philadelphia 7
Secaucus 7
Wageningen 7
Ambivere 6
Bengaluru 6
Jumet 6
Meppel 6
Zhengzhou 6
Abbiategrasso 5
Berlin 5
Central District 5
Elk Grove Village 5
Frankfurt am Main 5
Halle 5
Hanoi 5
Hong Kong 5
Mountain View 5
Mumbai 5
Rochester 5
St Petersburg 5
São Paulo 5
Taipei 5
Tappahannock 5
Torino 5
Vienna 5
Andover 4
Barcelona 4
Bochum 4
Ciudad Nezahualcoyotl 4
Florianópolis 4
Harbin 4
Islamabad 4
Lutz 4
Marburg 4
Osaka 4
Ottawa 4
Parma 4
Pescia 4
Sydney 4
Tokushima 4
Uetikon Am See 4
Zafra 4
Örebro 4
Auckland 3
Totale 7.513
Nome #
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 251
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 230
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 110
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 106
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 96
Research needs in allergy: an EAACI position paper, in collaboration with EFA 91
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 91
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 89
A critical appraisal on AIT in childhood asthma. 86
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 84
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 82
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 78
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 77
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 73
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 72
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 72
An academic allergy unit during COVID-19 pandemic in Italy. 71
Allergy in severe asthma. 67
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 66
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 64
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 62
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 60
Allergy in internet 60
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 59
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 58
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 58
Unexplained chronic cough and vitamin B-12 deficiency. 58
Adherence issues related to sublingual immunotherapy as perceived by allergists. 58
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 57
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 57
Nasal cytology: Methodology with application to clinical practice and research. 57
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 57
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 56
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 56
Determinants of exhaled nitric oxide in chronic rhinosinusitis 55
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 55
Acute asthma management during SARS-CoV2-pandemic 2020 55
Anaphylaxis after a horse bite 55
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 54
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 53
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 53
Level of exhaled nitric oxide during human anaphylaxis 53
Nasal nitric oxide in patients with inherited retinal dystrophies. 53
Microarray Immunodiagnostics for Aeroallergens 53
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 53
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 52
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 52
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 52
Acute urticaria presenting in the emergency room of a general hospital 52
Unexpected visitor: “hidden” food allergens 51
The Severe Asthma Network in Italy: Findings and Perspectives 51
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 51
Strategies to reduce corticosteroid-related adverse events in asthma 51
One year of mepolizumab. Efficacy and safety in real-life in Italy 51
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 51
TNF-alpha: a promising therapeutic target for asthma? 50
Asthma from immune pathogenesis to precision medicine 50
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 50
Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting of chronic cough 50
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 49
Interleukin-5 in the Pathophysiology of Severe Asthma 49
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 49
Exhaled nitric oxide in asthma. 48
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 48
Treatable traits in chronic rhinosinusitis with nasal polyps 48
Minimal clinically important difference for asthma endpoints: an expert consensus report 47
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 46
Eosinophils Target Therapy for Severe Asthma: Critical Points 46
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis 46
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 46
The pathway towards asthma control 45
Thunderstorm-related asthma epidemic owing to Olea Europaea pollen sensitization. 45
Omalizumab Treatment of Vernal Keratoconjunctivitis 45
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 45
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 45
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 45
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 45
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 45
Exhaled nitric oxide's ability to predict methacholine challenge: a matter of definition 44
Basophil activation test: a reliable biomarker for allergen immunotherapy? 44
Current insights in allergen immunotherapy. 44
Inhaled corticosteroids safety and adverse effects in patients with asthma 44
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study 44
Asthma: personalized and precision medicine 44
Exhaled nitric oxide in persistent rhinitis with or without lower airway involvement: a review of the literature. 44
Exhaled nitric oxide as a marker of diseases 44
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 44
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 43
Pigeon tick bite: A neglected cause of idiopathic nocturnal anaphylaxis. 43
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 43
Basophil Membrane Expression of Epithelial Cytokine Receptors in Patients with Severe Asthma. 43
Alpha1-antitrypsin deficiency and asthma 43
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 43
Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80. 42
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 42
Effect of arterial hypertension on chronic urticaria duration 42
Immunostimulants in respiratory diseases: Focus on Pidotimod 42
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 42
Occupational asthma due to Neurospora sitophila sensitization in a coffee dispenser service operator 41
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 41
Totale 5.903
Categoria #
all - tutte 82.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 0 0 0 0 0 27
2020/20212.629 35 80 47 28 23 781 345 228 467 311 43 241
2021/20221.422 62 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/2025535 128 105 78 106 118 0 0 0 0 0 0 0
Totale 10.404